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Background: Insufficient clearance by microglial cells, prevalent in several neurological conditions and diseases, is
intricately intertwined with MFG-E8 expression and inflammatory responses. Electromagnetic field (EMF) exposure
can elicit the pro-inflammatory activation and may also trigger an alteration of the clearance function in microglial
cells. Curcumin has important roles in the anti-inflammatory and phagocytic process. Here, we evaluated the ability
of curcumin to ameliorate the phagocytic ability of EMF-exposed microglial cells (N9 cells) and documented
relative pathways.
Methods: N9 cells were pretreated with or without recombinant murine MFG-E8 (rmMFG-E8), curcumin and an
antibody of toll-like receptor 4 (anti-TLR4), and subsequently treated with EMF or a sham exposure. Their phagocytic
ability was evaluated using phosphatidylserine-containing fluorescent bioparticles. The pro-inflammatory activation
of microglia was assessed via CD11b immunoreactivity and the production of tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), interleukin-1β (IL-1β) and nitric oxide (NO) via the enzyme-linked immunosorbent assay or the
Griess test. We evaluated the ability of curcumin to ameliorate the phagocytic ability of EMF-exposed N9 cells,
including checking the expression of MFG-E8, αvβ3 integrin, TLR4, nuclear factor-κB (NF-κB) and signal transducer
and activator of transcription 3 (STAT3) using Western blotting.
Results: EMF exposure dramatically enhanced the expression of CD11b and depressed the phagocytic ability of N9
cells. rmMFG-E8 could clearly ameliorate the phagocytic ability of N9 cells after EMF exposure. We also found that
EMF exposure significantly increased the secretion of pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) and the
production of NO; however, these increases were efficiently chilled by the addition of curcumin to the culture
medium. This reduction led to the amelioration of the phagocytic ability of EMF-exposed N9 cells. Western blot
analysis revealed that curcumin and naloxone restored the expression of MFG-E8 but had no effect on TLR4 and
cytosolic STAT3. Moreover, curcumin significantly reduced the expression of NF-κB p65 in nuclei and phospho-STAT3
(p-STAT3) in cytosols and nuclei.
Conclusions: This study indicates that curcumin ameliorates the depressed MFG-E8 expression and the attenuated
phagocytic ability of EMF-exposed N9 cells, which is attributable to the inhibition of the pro-inflammatory response
through the NF-κB and STAT3 pathways.* Correspondence: xuesenyyy@gmail.com
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The application of electromagnetic fields (EMFs) is ubi-
quitous in modern society [1]. Several epidemiological and
experimental studies have shown that EMF exposure may
have detrimental effects on cognitive function [2,3] and
may increase the risk of neurological diseases, such as
gliomas [4,5] and Alzheimer’s disease [6,7]. EMF exposure
has also been demonstrated to induce strong glial reac-
tivity in different brain regions [8-10]. We previously ob-
served that EMF exposure initiated the pro-inflammatory
activation of microglial cells [11]. However, to our know-
ledge, there is no evidence for how EMF exposure induces
depression of microglial phagocytosis.
The efficient removal of pathogens and cell debris by
activated microglial cells is fundamental for central ner-
vous system (CNS) development and homeostasis [12,13].
As an essential factor in the phagocytic process, milk-fat
globule EGF factor-8 (MFG-E8), which has a phospha-
tidylserine (PS) binding domain, has been confirmed as a
binding bridge between apoptotic cells and integrin αvβ3
on the surface of phagocytes [14,15]. A strong pro-in-
flammatory response was found in MFG-E8−/− mice [16].
Lipopolysaccharide (LPS), a potent stimulator of aberrant
innate immune functions during inflammation, signifi-
cantly decreases endogenous MFG-E8 levels in vivo and
in vitro via the toll-like receptor 4 (TLR4) signaling path-
way [17]. In contrast, the MFG-E8-mediated phagocytosis
of apoptotic cells results in an inhibition of inflammation
via the MAPK and nuclear factor-κB (NF-κB) signaling
pathways following the endotoxin response [18]. Thus,
these findings indicate that the role of MFG-E8 in regulat-
ing the immune reaction of microglial phagocytosis and
pro-inflammatory responses could depend on the types of
stimulus.
During the clearance process, it has been confirmed
that curcumin has an important role as an immunomod-
ulator in inhibiting neurotoxicity and increasing the
phagocytosis index [19,20]. Previous studies showed that
curcumin attenuates microglial migration and triggers a
phenotype with anti-inflammatory and neuroprotective
properties [21]. The activation of microglial cells can be
effectively inhibited by incubating them with curcumin,
which decreases the production of NO [22] and pro-
inflammatory cytokines, such as IL-1β, IL-6 and TNF-α
[23]. Moreover, curcumin is able to suppress the inflam-
matory signaling of NF-κB and the signal transducers and
activators of transcription (STATs) in LPS-stimulated
microglial cells [24,25]. However, the exact molecular
mechanisms underlying the salutary effect of curcumin on
microglial phagocytosis in inflammation remain largely
unknown.
N9 cells were used because they have been proven to
mimic primary microglia [26,27] and exhibit robust pro-
inflammatory and phagocytic responses [28]. In this study,we tested the following questions. Does EMF exposure
depress microglial phagocytosis during inflammation? If
EMF depresses phagocytosis, does curcumin directly regu-
late the depression of microglial phagocytosis or through
its anti-inflammatory effects? We demonstrated that the
inhibition of microglial pro-inflammatory responses by
curcumin restores MFG-E8-mediated phagocytosis after
EMF exposure. These results may assist in the deve-
lopment of appropriate microglia-targeted interventions
against neurological diseases.
Methods
Cell culture and treatments
N9 cells were cultured as described previously [26,27].
Briefly, cells were grown in Iscove’s modified Dulbecco’s
medium (IMDM) (HyClone, Logan, UT, USA) with
supplementary heat-inactivated fetal bovine serum (5%)
(HyClone), 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml
streptomycin, and 50 μM 2-mercaptoethanol (Sigma-
Aldrich, St Louis, MO, USA). Cells were seeded in 25 cm2
flasks (1 × 106 cells/ml), six-well plates (5 × 105 cells/well)
or 24-well plates (1.5× 105 cells/well) at 37°C in an incuba-
tor (37°C, 5% CO2). After 24 h incubation, the medium
was replaced with serum-free IMDM supplemented with
the following agents for different experiments: a solvent
control (tissue culture grade dimethylsulfoxide, Sigma-
Aldrich), curcumin (5, 10 and 20 μM, Sigma-Aldrich),
recombinant murine MFG-E8 (rmMFG-E8) (100, 500 and
1000 ng/ml), anti-TLR4 (10 μg/ml) (MTS510, HyCult
Biotechnology, Uden, Netherlands) and (+)-naloxone (1, 5
and 10 μM) (Sigma-Aldrich). After 1 h incubation, the
cells were exposed to EMF for 20 min before they were
subjected to staining or to extract proteins. To investigate
inflammation in the inhibition of phagocytosis and to en-
sure the proper concentration for the blocking antibody
was used in our experiments, the cells were treated with
Escherichia coli LPS (200 ng/ml) (Sigma-Aldrich) as a
positive control.
Exposure system
Household appliances, medical equipment and communi-
cation systems make extensive use of 2.45 GHz pulsed mi-
crowaves [11]. Cells were exposed to a pulsed EMF in an
anechoic chamber. The ambient air temperature inside
the anechoic chamber was 25°C to 26°C. Pulsed EMF
pulses (90 mW) were delivered through a rectangular
horn antenna connected horizontally to a handset (Philips
PM 7320X, Sivers IMA, Kista, Sweden). The pulse dura-
tion was 2 μs and the pulse repetition rate was 500 pulses
per second. The exposure was for 20 min to 2.45 GHz
pulsed microwaves at an average specific absorption rate
of 6 W/kg. During the exposure, the handset was oriented
vertically towards the cells at a distance of 90 cm. Flasks
and plates with cells were placed in the upper chamber of
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temperature of 37°C during the EMF exposure. The
temperature of the medium in the flasks in the upper
chamber was maintained at 37°C by circulating heated
water through a lower closed chamber. During the sham
exposures, control cells experienced the same conditions
but without EMF treatment.
Flow cytometry
Fluorescence-activated cell sorting (FACS) analysis quickly
evaluated microglial activation by detecting CD11b
expression. Briefly, N9 cells were washed three times in a
flow buffer (PBS containing 0.1% (w/v) sodium azide and
1% (w/v) BSA). The cells were then incubated with goat
serum (Zhongshan Goldenbridge Biotechnology (ZsBio),
Beijing, China) for 20 min at 4°C to block the non-specific
binding to Fc receptors. Cells were then spun (5,000 rpm,
5 min) and washed three times in the flow buffer. Subse-
quently, the cells were incubated with the rat anti-mouse
monoclonal antibody to CD11b (1:100) (AbD Serotec,
Oxford, UK) or the rat IgG2b isotype control (1:100)
(AbD Serotec) for 1 h at 4°C. Goat anti-rat IgG-
DyLightW549 (1:200) (AbD Serotec) was used as a second-
ary antibody. Cells were resuspended in ice-cold flow
buffer (250 μl). Quantitative analysis was performed
using a FACSCalibur system (BD Biosciences, San Jose,
CA, USA).
Immunofluorescent staining
Our phagocytic model used N9 cells to engulf fluores-
cent bioparticles (see detailed description below). Round
glass cover slips were placed in the well of 24-well plates
before seeding N9 cells. After the 20 min EMF exposure,
bioparticles (5 × 106 per well) were added to all wells
and incubated for different times. Bioparticles were
added 1 h before the indicated time points that the cells
were tested in the phagocytosis assay. Then the glass
cover slips were carefully taken out of the wells at differ-
ent times and rinsed twice in PBS. After being fixed and
permeabilized, the cells were blocked with goat serum
(ZsBio) for 20 min at room temperature and washed
three times in PBS. The cells were incubated with the
rat anti-mouse monoclonal antibody CD11b (1:100)
(AbD Serotec) at 37°C for 1 h. After washing three times
in PBS, the cells were incubated with the goat anti-rat
Alexa FluorW 488 secondary antibody (1:200) (Molecular
Probes, OR, USA) for 1 h at 37°C in the dark. The cover
slips with cells were washed three times in PBS and
mounted with an aqueous-based anti-fade mounting
medium on glass slides. Images of stained cells were
captured using a Leica TCS-SP5 confocal laser scanning
microscope (Leica, Mannheim, Germany). The confocal
images were acquired using Imaris software (version 7.6;
Bitplane, Zurich, Switzerland).Phagocytosis assay
We performed serial phagocytosis assays on 24-well
plates to evaluate the effects of EMF exposure on the
phagocytic actions of N9 cells. The appearance of PS on
the cellular plasma membrane is used by various phago-
cytes to recognize apoptotic cells. Therefore, we used a
PS-binding Alexa FluorW 647-conjugated Annexin V bio-
particles system to mimic phagocytosis. Briefly, a solution
of chloroform and methanol (19:1) was used to make PS
solution (10 mg/ml). A three fold amount (v/v) of Alexa
FluorW 647-conjugated Annexin V bioparticles was used
to dilute the PS solution; then another 300-fold amount of
IMDM (v/v) was added to the mixed PS solution and
incubated at 30°C for 30 min. The solution was then
sonicated three times for 10 s each at 10 kHz and centri-
fuged at 500 rpm for 10 min. The bioparticles were added
1 h before the indicated time points that the cells were
tested in the phagocytosis assay. Then, a washing step
with cold serum-free medium was performed to interrupt
any interaction between the phagocytosing microglia and
the uningested bioparticles.
The phagocytic ability of N9 cells was evaluated using
the fluorescence intensity of the engulfed bioparticles on a
plate reader and fluorescence microscopy. The fluores-
cence plate reader assay was conducted as explained in a
previous study [29]. Plates were read on a Tecan Infinite
M200 plate reader at an excitation wavelength of 643 nm
and an emission wavelength of 665 nm. The fluorescence
intensity of the bioparticles in the microscopy assay was
calculated as described in previous studies [30-32]. Five
replicates were used for each experimental condition. As a
negative control, wells with and without cells were used to
calculate the background fluorescence, which was then
subtracted from the experimental wells. The autofluores-
cence properties of the negative controls were indistin-
guishable. The positive control was N9 cells treated with
bioparticles alone.
Enzyme-linked immunosorbent assay of TNF-α, IL-6 and
IL-1β
The secretion of TNF-α, IL-6 and IL-1β into the culture
supernatant was measured using mouse ELISA kits
(eBioscience, San Diego, CA, USA). Briefly, 96-well ELISA
plates (NUNC MaxiSorp, eBioscience) were covered with
the capture antibody in the coating buffer (1:250, 100 μl/
well) overnight at 4°C. The wells were washed five times
with wash buffer (PBST: Phosphate-Buffered Saline with
0.05% of Tween-20) and blocked with assay diluent at
room temperature for 1 h. Culture media for the different
conditions were added to the wells (100 μl/well) and held
at 4°C to maximize sensitivity. The next day, the medium
was removed and the wells were washed three times in
PBST. The detection antibody (1:250, 100 μl/well) was
added to the wells. After 1 h incubation and following
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(1:250, 100 μl/well) for 30 min at room temperature. Each
plate was subsequently incubated with tetramethylbenzi-
dine substrate solution for 15 min. This reaction was
stopped with 50 μl of 2 N H2SO4 stop solution. Absorb-
ance values were measured at 450 nm using a microplate
spectrophotometer.
Nitric oxide determination in culture medium
The production of NO metabolites (nitrates and nitrites)
in the culture medium was quantified using a NO detec-
tion kit (Nanjing Jiancheng Bioengineering Institute,
Nanjing, China). This method uses nitrate reductase to
reduce NO3− to NO2− specifically, and the content of NO2−
was determined colorimetrically. Briefly, 100 μl of medium
was added to each well. Then, 50 μl of nicotinamide aden-
ine dinucleotide and nitrate reductase were added to each
well. After 30 min, Greiss reagents I and II (both 50 μl)
were added and incubated for 10 min at room temperature.
The optical density of each well was determined using a
microplate reader with an emission wavelength at 540 nm.
Western blotting
N9 cells were harvested from flasks and washed twice
with ice-cold PBS. The cells were lysed in RIPA lysis
buffer (Roche, Penzberg, Germany) containing protease
and phosphatase inhibitors (Roche) for 30 min on ice.
Lysates were centrifuged at 12,000 rpm for 10 min at 4°C.
Some cells were lysed with the Proteo JET™ Cytoplasmic
and Nuclear Protein Extraction Kit (MBI Fermentas, MD,
USA) to extract nuclear proteins, or the Proteo JET™
Membrane Protein Extraction Kit (MBI Fermentas) to ex-
tract membrane proteins. The protein concentration
was determined using the bicinchoninic acid method
(Beyotime Biotech, Beijing, China). SDS-PAGE (10%)
was used to separate the proteins (whole proteins includ-
ing MFG-E8, 50 μg; membrane proteins including αvβ3,
50 μg; cytoplasmic proteins including pTyr705-STAT3
and STAT3, 50 μg; or nuclear proteins including pTyr705-
STAT3 and NF-κB, 20 μg). Protein bands were transferred
on to nitrocellulose membranes (Millipore, Bedford, MA,
USA) at 4°C. The membranes were blocked in PBS with
5% non-fat milk for 1 h and then incubated with primary
antibodies recognizing MFG-E8 (1:500) (Santa-Cruz Bio-
technology, Santa Cruz, CA, USA), αvβ3 integrin (1:1000)
(Millipore), phospho-STAT3 (p-STAT3) (1:1000) (Cell Sig-
naling Technology, Danvers, MA, USA), STAT3 (1:1000)
(Cell Signaling Technology) and p65 NF-κB (1:1000) (Cell
Signaling Technology) at 4°C overnight. Membranes were
washed four times for 5 min each in tris-buffered saline
plus 0.1% Tween-20 (TBST). A fluorescently labeled sec-
ondary antibody (IRDyeW 800CW donkey anti-mouse IgG
(H + L) and IRDyeW 680RD donkey anti-rabbit IgG (H +
L), (1:5000) (LI-COR, Lincoln, NE, USA) was used to bindthe primary antibodies for 1 h at room temperature with
gentle shaking in a dark area. After washing in TBST (four
times, 5 min each), the protein bands were illuminated
and quantified using an Odyssey infrared imaging system
(LI-COR). Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (1:1000) (Cell Signaling Technology) and prolif-
erating cell nuclear antigen (PCNA) (1:500) (Santa Cruz)
were used as internal controls for cytoplasmic protein and
nuclear protein, respectively. Protein bands were semi-
quantified by densitometric analysis using ImageJ 1.46.
Statistical analysis
Statistical analysis was performed using SPSS software.
Each experiment was repeated a minimum of three times
and the data expressed as means ± SEM. Statistical differ-
ences between the groups were assessed by two-way
ANOVA followed by Tukey’s test. Statistical significance
was established at P < 0.05, unless otherwise indicated.
Results
Alteration of phagocytic ability of N9 cells after EMF
exposure
EMF exposure dramatically enhanced the expression of
CD11b but reduced the phagocytic ability of N9 cells.
The expression of CD11b was measured using FACS
analysis of the N9 cells cultured in different conditions
(Figure 1A). The fluorescent light of the CD11b dye
(FL2 channel) generates an electronic signal that can be
recorded as high (FL2-H) for the intensity of the stain-
ing. The intensity of the staining calculated from FL2-H
showed that CD11b expression was quite similar in N9
cells incubated with curcumin and the control group
(about 3.8 and 3.9, respectively, Figure 1B). But at 12 h
after EMF exposure the expression of CD11b was signifi-
cantly enhanced (12.2) compared to the control (P < 0.05,
Figure 1B). Curcumin incubation can effectively neutralize
the enhancement of CD11b expression (5.7) after EMF
exposure of N9 cells, though the expression level was still
higher than for the controls (Figure 1B).
The microscopy assay showed that the normalized
phagocytic ratio was 112% at 3 h after EMF exposure,
which was similar to that of the control (normalized to
100%) (Figure 1C,D). The normalized ratio dramatically
dropped to 37% at 12 h post EMF exposure compared
to the control (P < 0.05, Figure 1D). Using a fluorescence
intensity assay of phagocytosis, we observed that each
group of N9 cells ingested a different number of biopar-
ticles. Compared to the phagocytic ratio in control cells,
the ratio was slightly higher in cells at 1 h (105%) and
3 h (112%) after EMF treatment (Figure 1D), but it
decreased to 92% in cells after 6 h and was significantly
reduced after 12 h (36%, P < 0.05, Figure 1D). These re-
sults indicate that EMF may be a potential risk factor for
impaired microglial phagocytosis.
Figure 1 Reduction of phagocytic ability of N9 cells after EMF exposure. N9 cells were pretreated with (+) or without (−) curcumin (20 μM) for
1 h and then exposed to 2.45 GHz EMF (+) or sham exposed (−) for 20 min. Untreated cultures were used as controls. (A) Representative flow cytometry
histograms for CD11b expression at 12 h after EMF exposure. The fluorescence intensity in the FL2-H channel (X-axis) reflects CD11b content. (B) Average
values of mean fluorescence intensity of CD11b from three independent experiments normalized to the control. (C) Confocal and constructed 3D images
of N9 cells used as controls, and 3 h and 12 h after EMF exposure. Scale bar: 25 μm. (D) Average fluorescence intensity of microspheres ingested per
group estimated using the confocal images and multifunctional microplate reader. *P< 0.05 vs the sham-exposed control group; #P< 0.05 vs the EMF-
exposed group. con, control; Cur, curcumin; DAPI, 4',6-diamidino-2-phenylindole; EMF, electromagnetic field.
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phagocytic depression
EMF exposure significantly depressed the expression of
MFG-E8 in N9 cells. We found that the MFG-E8 levels
in N9 cells from 0 h to 6 h after EMF treatment were
quite similar to those of the controls. The normalized
MFG-E8 expression in N9 cells increased about 0.4 fold
compared to the internal control (GAPDH) (Figure 2A,B).
However, MFG-E8 levels dramatically dropped to about
0.1 fold in N9 cells at 12 h after the EMF exposure
(Figure 2A,B). Interestingly, the expression of αvβ3 integ-
rins was not affected by EMF exposure and the
normalized fold changes were quite stable (around 0.06
fold increase) (Figure 2A,B). These results indicated that
MFG-E8 expression was significantly inhibited at 12 h
after EMF exposure.
We tested whether the lower MFG-E8 expression
depressed phagocytic ability. The normalized phagocyticratio dropped to 36% for cells exposed to EMF compared
with the sham-exposed controls (normalized to 100%,
Figure 2C,D) (P < 0.05). When the culture medium was
supplied with rmMFG-E8 (500 ng/ml), the ratio increased
to 154% (Figure 2C,D), which was significantly higher
than for the control (P < 0.05). We also found that the
phagocytic ability increased with the concentration of
rmMFG-E8 (100 ng/ml, 500 ng/ml and 1,000 ng/ml). The
phagocytic ratios were 45%, 88% and 94% (Figure 2C,D),
respectively.
All of these results demonstrate that EMF expos-
ure can clearly reduce the phagocytic ability of N9
cells but addition of rmMFG-E8 can compensate for
the reduction. Our observations confirm that rmMFG-
E8 can significantly enhance phagocytosis and restore
phagocytic ability in EMF-exposed N9 cells compared
to sham-exposed controls. These findings indicate that
MFG-E8 plays an important role in phagocytosis.
Figure 2 Improvement in phagocytic ability for EMF-exposed N9 cells with the addition of MFG-E8. N9 cells were pretreated with (+) or
without (−) various concentrations of rmMFG-E8 (100, 500 and 1,000 ng/ml) for 1 h and then exposed to 2.45 GHz EMF (+) or sham exposed
(−) for 20 min. (A) Levels of MFG-E8 and αvβ3 in total cell lysates and cellular membrane fractions were analyzed using Western blotting at the indi-
cated times for EMF-stimulated N9 cells. Western blot results confirmed downregulation of MFG-E8, but not αvβ3, at 12 h after EMF exposure. (B) The
MFG-E8 and αvβ3/actin ratios were determined by densitometric analysis. (C) rmMFG-E8 pretreatment significantly improved the phagocytic
ability of N9 cells at 12 h after EMF exposure. Scale bar: 10 μm. (D) Phagocytic ratios were calculated from (C). *P < 0.05 vs the sham-exposed
control group; #P < 0.05 vs the EMF-exposed group. con, control; EMF, electromagnetic field; MFG-E8, milk-fat globule EGF factor-8; rmMFG-E8,
recombinant murine MFG-E8.
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phagocytic depression
Given the different changes of CD11b expression and
phagocytic ability in N9 cells after EMF exposure, we
measured levels of TNF-α, IL-1β, IL-6 and NO in cell
culture medium supernatants at various times after EMF
exposure. ELISA indicated that the secretion of TNF-α,
IL-1β and IL-6 was quite low in the sham-exposed
control cells and the cells treated with curcumin at all
time points (Figure 3A,B,C). The expression of the three
cytokines significantly increased in N9 cells after EMF
exposure and reached a maximum at 12 h (Figure 3A,B,C).
A similar pattern was observed when cells were treated
with LPS as a positive control. Dramatically, the expression
of the three cytokines dropped to the baseline level in
EMF-exposed or LPS-treated N9 cells cultured with
curcumin (Figure 3A,B,C). Similarly, no differences were
found for the production of nitrite between control cells
and curcumin-treated cells (Figure 3D). The levels of
nitrite in the media significantly increased after EMF
exposure or LPS treatment compared to the control
(Figure 3D). The production of NO reduced when curcu-
min was used to incubate N9 cells after EMF exposureFigure 3 Inhibition by curcumin of TNF-α, IL-1β, IL-6, and NO in EMF-
20 μM curcumin for 1 h, and then stimulated with 200 ng/ml LPS or a 20-m
normalized compared to total protein in cell lysates. The concentrations of
ELISA after the cells were treated at the indicated times. (D) The amount o
stimulation significantly increased the secretion of TNF-α, IL-1β and IL-6 an
for N9 cells exposed to EMF. Curcumin neutralized the effect in EMF-expos
#P < 0.05, ##P < 0.01 vs the EMF-exposed group. con, control; Cur, curcumin
TNF-α, tumor necrosis factor α.(Figure 3D). In addition, levels of the microglial activation
marker CD11b were significantly attenuated by curcumin
preconditioning (Figure 1A,B).
The phagocytic ratio was quite similar in the controls
and N9 cells incubated in curcumin but without EMF
exposure (100% vs 96%). The normalized phagocytic
ratio at 12 h was as low as 37% for N9 cells treated with
EMF and 35% for cells treated with LPS, which was
significantly lower than the sham-exposed controls and
curcumin-incubated cells (P < 0.05, Figure 4A,B). Clearly,
at 12 h the phagocytic ratio had improved from 6% to
43% in the EMF-exposed N9 cells supplied with curcu-
min compared to EMF-treated cells (Figure 4A,B). There
was a dose-dependent change in phagocytic ability for
N9 cells incubated with curcumin after EMF exposure
(Figure 4A,B). These results suggest that the inhibition
of microglial pro-inflammatory activation improves the
phagocytic ability of N9 cells.
TLR4 is not involved in chilling the pro-inflammatory
response and the amelioration of phagocytosis by curcumin
Curcumin alone did not increase the phagocytic ability
(Figure 4A,B) or the expression of MFG-E8 (Figure 5A)exposed N9 cells. N9 cells were pretreated with (+) or without (−)
in EMF exposure for the indicated times. Levels for each sample were
TNF-α (A), IL-1β (B) and IL-6 (C) in the medium were determined by
f nitrite was determined by the Griess reaction. EMF exposure and LPS
d the production of NO in a time-dependent manner from 1 h to 12 h
ed N9 cells. *P < 0.05, **P < 0.01 vs the sham-exposed control group;
; EMF, electromagnetic field; IL, interleukin; LPS, lipopolysaccharide;
Figure 4 Amelioration by curcumin of phagocytic ability for EMF-exposed N9 cells. N9 cells were pretreated with (+) or without (−) various
concentrations of curcumin (5, 10 and 20 μM) for 1 h and then exposed to 2.45 GHz EMF (+) or sham exposed (−) for 20 min. (A) Curcumin
pretreatment concomitantly improves microglial phagocytosis in a dose-dependent manner at 12 h after EMF exposure. No increase in microglial
phagocytosis was detected upon curcumin preconditioning in the sham exposure group. Scale bar: 10 μm. (B) Quantification of the phagocytic
ability of N9 cells was calculated from (A). The phagocytic ratio was significantly improved in the EMF-exposed or 200 ng/ml LPS-treated N9 cells
incubated with 10 μM and 20 μM of curcumin. *P < 0.05 vs the sham-exposed control group; #P < 0.05 vs the EMF-exposed group. con, control;
Cur, curcumin; EMF, electromagnetic field; LPS, lipopolysaccharide.
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the improvement of microglial phagocytosis was not dir-
ectly regulated by curcumin alone. The normalized fold
change of protein expression showed that EMF exposure
clearly inhibited the expression of MFG-E8 compared to
the sham exposure controls (0.11 vs 0.43, Figure 5A,B).
An increasing trend of fold change was found for MFG-
E8 expression when the EMF-exposed N9 cells were
incubated with curcumin (from 0.14 to 0.39, Figure 5A)
or naloxone (another anti-inflammatory factor, from
0.14 to 0.22, Figure 5B).
We also tested whether the restoration of MFG-E8-
mediated phagocytosis by curcumin was due to the regu-
lation of TLR4. The expression of TLR4 remained at thebasal level for each condition, including the curcumin-
treated group. The expression of TLR4 was not affected
by the addition of curcumin or naloxone, which is a TLR4
inhibitor (Figure 5B). The normalized fold changes were
quite similar in all groups (all around 0.50). However,
in the TLR4 antibody blocking experiment, the anti-
TLR4 antibody did not improve the expression of MFG-
E8 (Figure 6C) or ameliorate the phagocytic ratio
(Figure 6A,B) in N9 cells treated with EMF. As a positive
control, LPS treatment significantly depressed microglial
phagocytosis, and this was reversed by the anti-TLR4 anti-
body (Figure 6A,B). These findings show that the TLR4
pathway might not be involved in the curcumin-mediated
improvement of defective phagocytosis.
Figure 5 Restoration of MFG-E8 expression in EMF-exposed N9 cells incubated in curcumin and naloxone. N9 cells were pretreated with
(+) or without (−) various concentrations of curcumin (5, 10 and 20 μM) or naloxone (1, 5 and 10 μM) for 1 h, and then exposed to 2.45 GHz EMF
(+) or sham exposed (−) for 20 min. GAPDH antibody was used as a control for equal protein loading. The pro-inflammatory inhibitors curcumin
(A) and naloxone (B) significantly restored the expression of MFG-E8 in a dose-dependent manner at 12 h after EMF exposure but there was no
change in TLR4 expression for all groups. Curcumin or naloxone pretreatment alone did not cause significant changes in MFG-E8 expression in
the sham exposure group. *P < 0.05 vs the sham-exposed control group; #P < 0.05 vs the EMF-exposed group. Cur, curcumin; EMF, electromagnetic
field; MFG-E8, milk-fat globule EGF factor-8; Nal, naloxone; TLR4, toll-like receptor 4.
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phagocytic ability
These findings above show that the improvement of
phagocytic ability is not directly regulated by TLR4
through inhibition of the pro-inflammatory responses in
N9 cells. Next we studied the anti-inflammatory role of
curcumin and revealed that it inhibited the NF-κB and
STAT3 pro-inflammatory pathways. Western blot ana-
lysis indicated that the addition of curcumin modified
the expression of p-STAT3 but not STAT3 in EMF-
exposed N9 cells (Figure 7A). The normalized fold
change (0.40 to 0.49) of STAT3 was quite stable in the
controls and other groups treated with EMF (Figure 7A).
But an obvious increase of p-STAT3 expression was
found in EMF-treated N9 cells (Figure 7A,B). After the
addition of curcumin to the culture medium, the expres-
sion of p-STAT3 and NF-κB was chilled down to the
baseline level of around 0.30 and 0.46 fold compared to
the controls for EMF-exposed N9 cells (Figure 7A,B).
These results suggested that curcumin may ameliorate
defective microglial phagocytosis via the inhibition of
NF-κB activation and STAT3 phosphorylation, but not
through alteration of TLR4 signaling.
Discussion
In the present study, we observed the alteration of the in-
flammatory response and phagocytosis for EMF-exposed
N9 cells. We found significant decreases of phagocyticability and MFG-E8 expression at 12 h in N9 cells after
EMF exposure. The reduction of phagocytosis can be
ameliorated in N9 cells incubated with rmMFG-E8. The
pro-inflammatory response induced by the EMF exposure
was significantly inhibited by curcumin. Interestingly,
there was no detectable change in MFG-E8 expression
when the TLR4 antibody was supplied to N9 cells, but it
was altered by naloxone. Importantly, the STAT3 and NF-
κB pro-inflammatory pathways were significantly inhibited
by curcumin too. This suggests that curcumin ameliorates
EMF-mediated phagocytic depression in N9 cells via the
immune regulation of MFG-E8 by the STAT3 and NF-κB
pathways.
The primary effects of microglial activation in response
to injury and stimuli are the pro-inflammatory and phago-
cytic responses. It has been reported that pro-inflammatory
cytokines act selectively to regulate the different types of
microglial phagocytosis [33]. Our results reveal that high
levels of pro-inflammatory cytokines were released at 12 h
after EMF exposure and this was accompanied by impaired
microglial phagocytosis. In the unconjugated bilirubin
activated microglial cell model, phagocytosis was similarly
downregulated for a certain time period, while consider-
able amounts of pro-inflammatory cytokines were released
[34]. Inflammation-induced aberrant innate immune func-
tions can be prevented by the inhibition of inflammatory
processes [17,18,35,36]. As our results demonstrate, in-
hibition of the EMF-induced pro-inflammatory response
Figure 6 There was no change in the phagocytic ability of EMF-exposed N9 cells incubated in anti-TLR4 antibody. Experiments were
performed at 12 h after EMF exposure or 200 ng/ml LPS treatment as described above. (A,B) Anti-TLR4 antibody (10 μg/ml) pretreatment had no
effect on microglial phagocytosis. As a positive control, anti-TLR4 antibody prevented LPS-induced depression of microglial phagocytosis. Scale
bar: 10 μm. (C) No significant changes in MFG-E8 expression were detected upon anti-TLR4 antibody preconditioning. *P < 0.05 vs the sham-exposed
control group; #P < 0.05 vs the EMF-exposed group. con, control; EMF, electromagnetic field; LPS, lipopolysaccharide; MFG-E8, milk-fat globule EGF
factor-8; TLR4, toll-like receptor 4.
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cells. But no increase in phagocytic ability was detected in
the control groups after addition of curcumin. Thus, the
pro-inflammatory response may be associated with the
downregulation of microglial phagocytosis in EMF-treated
N9 cells.
EMF exposure can decrease microglial phagocytosis
due to downregulated MFG-E8 expression in N9 cells. It
has been well known that microglial cells phagocytoseapoptotic cells through a process of migration, disfigur-
ation and recognition [37,38]. The recognition of apoptotic
cells is mediated by some specific receptors, such as the PS
receptor [39] and αvβ3 [15]. The soluble PS-binding
protein MFG-E8 is required for the recognition and
phagocytosis of PS-exposing cells [14,15,40]. MFG-E8
deficiency is accompanied by the induction of pro-inflam-
matory cytokines and the impaired uptake of apoptotic cells
in several inflammatory diseases, including systemic lupus
Figure 7 Involvement of NF-κB and STAT3 signaling in EMF-exposed N9 cells incubated in curcumin. N9 cells were pretreated with (+) or
without (−) curcumin (20 μM) for 1 h, and then exposed to 2.45 GHz EMF (+) or sham exposed (−) for 20 min. Untreated cultures were used as a
control. Curcumin pretreatment before EMF exposure significantly inhibits the STAT3 (A) and NF-κB (B) pro-inflammatory pathways. The nuclear
extracts were prepared for Western blot analysis using antibodies against p65 NF-κB or PCNA (used as a loading control). *P < 0.05 vs the
sham-exposed control group; #P < 0.05 vs the EMF-exposed group. con, control; Cur, curcumin; EMF, electromagnetic field; NF-κB, nuclear factor-κB;
PCNA, proliferating cell nuclear antigen; p-STAT3, phospho-STAT3; STAT, signal transducer and activator of transcription.
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our study, microglial phagocytosis was decreased in a pro-
inflammatory environment at 12 h after EMF exposure,
with a parallel decrease in MFG-E8 expression. But the
supply of rmMFG-E8 significantly restored microglial
phagocytosis. These results suggest that a failure to remove
the dying cells dues to a decrease in MFG-E8 expression
induced by the pro-inflammatory response. Thus, the pro-
inflammatory response appears to cause the non-redundant
immune suppression of MFG-E8 expression and microglial
phagocytosis after EMF exposure.
Theoretically, TLR-mediated responses can regulate
the responses required to eliminate cell debris and pro-
mote repair efficiently. Animals that received a single
microinjection of TLR2 or TLR4 ligands at the site of
sciatic nerve lesions cleared the degenerating myelin
faster and recovered earlier than saline-injected control
rats [43]. Moreover, the expression of these innate immune
receptors by microglia is a natural defense mechanism to
prevent β-amyloid peptide accumulation in the CNS [44].
It is recognized that downregulation of MFG-E8 produc-
tion during sepsis is primarily dependent on activation of
the LPS-CD14-TLR4 pathway, and that phagocytosis of
apoptotic cells is associated with the TLR4-MFG-E8 path-
way [17,45]. However, in our study TLR4 expression was
not altered by curcumin or naloxone in EMF-exposed N9
cells. Our results also showed that the anti-TLR4 antibody
had no effect on MFG-E8 expression and microglial
phagocytosis in EMF-exposed N9 cells. Altogether, the
regulation of MFG-E8 expression by the pro-inflammatoryresponse under our experimental conditions was not medi-
ated by TLR4. We propose that MFG-E8-dependent alter-
ations in microglial phagocytosis are not due to the direct
regulation of the TLR4 pathway, but rather to the indirect
activity of downstream factors related to pro-inflammatory
signaling at 12 h after EMF exposure.
Pro-inflammatory cytokines can promote self-propagat-
ing cycles of microglial activation by inducing the activa-
tion of NF-κB and STAT3, leading to cytokine generation,
followed by further activation of NF-κB and STAT3
[46-48]. We reported a possible autocrine loop involving
positive feedback between microglial activation and cyto-
kine production [49]. Consistent with the inhibition of
pro-inflammatory mediators by curcumin, we observed an
anti-inflammatory role of curcumin via inhibition of the
STAT3 and NF-κB pro-inflammatory pathways. Therefore,
the NF-κB and STAT3 pathways are potentially involved
in the anti-inflammatory therapeutic effects of curcumin
in a variety of neuropathologies. In support of this,
curcumin has been found to block the LPS-mediated
induction of cyclooxygenase-2 through inhibition of
NF-κB and STAT3 [24,25]. Although the beneficial ef-
fects of curcumin can be observed under various expe-
rimental conditions, the effects of curcumin in microglial
cells exposed to EMF remain to be fully elucidated. Fur-
ther experiments are required to explore the detailed
mechanisms underlying this process. Regardless of the
mechanism, the data presented in this study may assist
future studies that aim to determine the therapeutic
potential of curcumin.
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Our data indicate that pro-inflammatory mediators
released by EMF-activated microglia can regulate the ex-
pression of MFG-E8, thus decreasing MFG-E8-dependent
microglial phagocytosis. The addition of curcumin pre-
vented EMF-induced reductions in microglial phagocytosis
and MFG-E8 expression via the inhibition of the pro-
inflammatory response. Moreover, curcumin ameliorated
phagocytic ability via the prevention of pro-inflammatory
activity in an NF-κB- and STAT3-dependent manner with-
out the involvement of TLR4. The modulatory effects of
curcumin may have potential for drug discovery for neu-
roinflammatory disorders.
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